Publications:29
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsAaron M Etra, MD
Internal Medicine, Hematology-Oncology, Cancer (Oncology)
No Patient Experience Ratings
Book an Appointment
About Me
Aaron Etra, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai and a member of The Tisch Cancer Institute. His clinical practice focus is on autologous and allogeneic stem cell transplantation for acute myeloid leukemia, myelodysplastic syndromes, acute lymphoblastic leukemia, bone marrow failure syndromes, lymphoma, and multiple myeloma. Dr. Etra provides evidence-based care that is compassionate and patient-centered.
Dr. Etra’s research interests include acute graft-versus-host disease (aGVHD), a primary cause of non-relapse mortality following allogeneic stem cell transplantation, and infectious complications post-transplant. He is a member of the Mount Sinai Acute GVHD International Consortium (MAGIC), which promotes development and testing of innovative treatment approaches for aGVHD.
Dr. Etra is an investigator on numerous clinical trials, including MAGIC observational studies and trials that investigate novel agents for both low-risk and high-risk GVHD. He is the site principal investigator at Mount Sinai for trials of the Blood and Marrow Transplant Clinical Trials Network that are focused on developing tools for predicting non-relapse mortality in transplant patients and identifying improved GVHD prophylaxis and treatment regimens.
The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Aaron Etra, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai and a member of The Tisch Cancer Institute. His clinical practice focus is on autologous and allogeneic stem cell transplantation for acute myeloid leukemia, myelodysplastic syndromes, acute lymphoblastic leukemia, bone marrow failure syndromes, lymphoma, and multiple myeloma. Dr. Etra provides evidence-based care that is compassionate and patient-centered.
Dr. Etra’s research interests include acute graft-versus-host disease (aGVHD), a primary cause of non-relapse mortality following allogeneic stem cell transplantation, and infectious complications post-transplant. He is a member of the Mount Sinai Acute GVHD International Consortium (MAGIC), which promotes development and testing of innovative treatment approaches for aGVHD.
Dr. Etra is an investigator on numerous clinical trials, including MAGIC observational studies and trials that investigate novel agents for both low-risk and high-risk GVHD. He is the site principal investigator at Mount Sinai for trials of the Blood and Marrow Transplant Clinical Trials Network that are focused on developing tools for predicting non-relapse mortality in transplant patients and identifying improved GVHD prophylaxis and treatment regimens.
The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- AL Amyloidosis
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Transplantation
- Bone Marrow Transplantation, Allogeneic
- Bone Marrow Transplantation, Autologous
- Hematologic Malignancies
- Hematology
Show More
Education
MD, Albert Einstein College of Medicine
Internship, Internal Medicine
Mount Sinai Beth Israel
Residency, Internal Medicine
Mount Sinai Beth Israel
Fellowship, Hematology & Oncology
Mount Sinai Hospital and Medical Center
Certifications
American Board of Internal Medicine
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Ruttenberg Treatment Center1470 Madison Avenue, 3rd Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group. Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, Ingrid Vasova, Francis Ayuk, Hannah Choe, William Hogan, Zachariah DeFilipp, Muna Qayed, Aaron M. Etra, Karam Sandhu, Sabrina Kraus, Tim Olson, Elizabeth Hexner, Paibel Aguayo-Hiraldo, Ran Reshef, Evelyn Ullrich, Tal Schechter, Carrie Kitko, Chantiya Chanswangphuwana, Pietro Merli, Yu Akahoshi, Janna Baez, Gilbert Eng, Rahnuma Beheshti, Steven Kowalyk, George Morales, Ioannis Evangelos Louloudis, Rachel Young, Ernst Holler, Ryotaro Nakamura, James L.M. Ferrara, John E. Levine. Transplantation and Cellular Therapy
- Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's disease. Daniela Guisado, Sayali Talware, Xiaoli Wang, Andrew Davis, Elbek Fozilov, Aaron Etra, Jean Frederic Colombel, Christoph Schaniel, Christopher Tastad, John E. Levine, James L.M. Ferrara, Chuang Ling-Shiang, Ksenija Sabic, Shishir Singh, Bridget K. Marcellino, Ronald Hoffman, Judy Cho, Louis Cohen. Gut
- Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients. Carlos A.Ortega Rios, Muna Qayed, Aaron M. Etra, Ran Reshef, Richard Newcomb, Nicholas Yuhasz, Elizabeth O. Hexner, Paibel Aguayo-Hiraldo, Pietro Merli, William J. Hogan, Daniela Weber, Carrie L. Kitko, Francis Ayuk, Matthias Eder, Stephan A. Grupp, Sabrina Kraus, Karam Sandhu, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Nikolaos Katsivelos, Steven Kowalyk, Ioannis Evangelos Louloudis, George Morales, Nikolaos Spyrou, Rachel Young, Ryotaro Nakamura, John E. Levine, James L.M. Ferrara, Yu Akahoshi. Transplantation and Cellular Therapy
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Etra during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Incyte Corporation
- Other
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Etra during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Incyte Corporation
- Other
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.